• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质性肺疾病患者对症状、严重程度评分的全球印象,以及随时间变化的可衡量性的意义。

Interstitial Lung Disease Patients' Global Impressions of Symptoms, Severity Ratings, and Meaningfulness of Changes Over Time.

机构信息

Center for Interstitial Lung Disease, National Jewish Health, Denver, Colorado; and.

Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, New York.

出版信息

Ann Am Thorac Soc. 2024 Dec;21(12):1670-1677. doi: 10.1513/AnnalsATS.202405-457OC.

DOI:10.1513/AnnalsATS.202405-457OC
PMID:39133575
Abstract

In interstitial lung disease (ILD), symptoms drive impairments in health-related quality of life. Patient-reported outcome measures (PROMs) can assess whether interventions change symptom severity. The meaningfulness of change in a PROM score is estimated by anchoring it to a related variable for which meaningful change has been previously established. Patient global impressions of severity (PGISs) are single-item PROMs that may make trustworthy anchors, but, for ILD, the meaningfulness of change in PGIS items for shortness of breath (SOB), cough, and fatigue/low energy are unknown. To improve understanding of how patients with ILD rate and categorize symptoms, how differing levels of symptom severity affect lived experiences, and how patients derive and apply meaningfulness to change in symptoms. We used one-on-one interviews and an electronic survey to collect data from patients with various forms of ILD. Interviews were conducted to provide richness and context to survey responses. We conducted certain analyses with respondents stratified by supplemental oxygen use. Interviewees ( = 18) confirmed SOB, cough, and fatigue/low energy as the most bothersome symptoms of ILD. Among 298 survey respondents, on a PGIS for SOB with a 0-4 numeric rating scale, on average, those who used supplemental O had more severe SOB than nonusers, and most respondents considered a 2-point change meaningful for worsening (45.5%) or improvement (47.2%). On a PGIS with a five-option ordinal response scale, for SOB, most considered a 1-category change meaningful for worsening (49.8%) and a 2-category change meaningful for improvement (42.3); for cough frequency, most respondents considered a 1-category change on the five-option ordinal response scale meaningful for worsening (48.2%) or improvement (45.0%). Survey responses for SOB at the present time versus 3 months earlier (patient global impressions of change) were biased toward the present state. PGISs can be used as anchors for meaningful change analyses of PROMs that assess SOB or cough in patients with ILD. Patient global impressions of change demonstrate present-state bias and should not be used. Patients' descriptions paint a vivid picture of lived experience with varying levels of symptom severity and can help contextualize change scores.

摘要

在间质性肺病 (ILD) 中,症状会导致健康相关生活质量受损。患者报告的结局测量 (PROM) 可评估干预措施是否改变症状严重程度。通过将其与先前已确定有意义变化的相关变量相关联,可以估计 PROM 评分变化的意义。患者总体印象严重程度 (PGIS) 是单项 PROM,可能成为可靠的锚定物,但对于 ILD,PGIS 项目对呼吸急促 (SOB)、咳嗽和疲劳/低能量的变化的意义尚不清楚。为了更好地了解ILD 患者如何评估和分类症状,不同程度的症状严重程度如何影响生活体验,以及患者如何理解和应用症状变化的意义,我们使用一对一访谈和电子调查从各种形式的ILD 患者中收集数据。访谈是为了提供调查结果的丰富性和背景。我们根据是否使用补充氧气对受访者进行了某些分析。受访者 ( = 18) 确认呼吸急促、咳嗽和疲劳/低能量是ILD 最困扰的症状。在 298 名调查受访者中,在 SOB 的 PGIS 上使用 0-4 数字评分量表,平均而言,使用补充氧气的患者的 SOB 比非使用者更严重,大多数受访者认为恶化 (45.5%) 或改善 (47.2%) 的 2 分变化具有意义。在 SOB 的 PGIS 上使用五选项有序反应量表,对于 SOB,大多数人认为恶化 (49.8%) 和改善 (42.3%) 的 1 类变化具有意义;对于咳嗽频率,大多数受访者认为五选项有序反应量表上的 1 类变化在恶化 (48.2%) 或改善 (45.0%) 方面具有意义。现在与 3 个月前的 SOB 患者总体印象变化 (患者对变化的总体印象) 调查结果偏向于现在的状态。PGIS 可用于评估 ILD 患者 SOB 或咳嗽的 PROM 有意义变化分析的锚定物。患者总体印象变化显示出现在状态的偏差,不应使用。患者的描述生动地描绘了不同严重程度症状的生活体验,并有助于上下文变化分数。

相似文献

1
Interstitial Lung Disease Patients' Global Impressions of Symptoms, Severity Ratings, and Meaningfulness of Changes Over Time.间质性肺疾病患者对症状、严重程度评分的全球印象,以及随时间变化的可衡量性的意义。
Ann Am Thorac Soc. 2024 Dec;21(12):1670-1677. doi: 10.1513/AnnalsATS.202405-457OC.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
5
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
6
Using Bookmarking to Reveal Dyspnea Severity Categorizations According to Patients with Interstitial Lung Disease and the Physicians Who Treat Them.利用书签揭示间质性肺疾病患者及其治疗医生对呼吸困难严重程度的分类。
Ann Am Thorac Soc. 2025 Aug;22(8):1147-1154. doi: 10.1513/AnnalsATS.202411-1215OC.
7
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
10
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.

引用本文的文献

1
Anchoring Patient Voices to Shape the Future of Patient-reported Outcomes.锚定患者声音,塑造患者报告结局的未来。
Ann Am Thorac Soc. 2024 Dec;21(12):1651-1652. doi: 10.1513/AnnalsATS.202410-1028ED.

本文引用的文献

1
The challenges inherent with anchor-based approaches to the interpretation of important change in clinical outcome assessments.基于锚定的方法在解释临床结局评估中重要变化时所固有的挑战。
Qual Life Res. 2023 May;32(5):1239-1246. doi: 10.1007/s11136-022-03297-7. Epub 2022 Nov 18.
2
Likely change indexes improve estimates of individual change on patient-reported outcomes.可能改变指标可改善患者报告结局个体变化的估计。
Qual Life Res. 2023 May;32(5):1341-1352. doi: 10.1007/s11136-022-03200-4. Epub 2022 Aug 3.
3
Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures.
构建进行性纤维化间质性肺疾病症状与影响的概念模型,以评估患者报告的结局指标。
ERJ Open Res. 2022 May 3;8(2). doi: 10.1183/23120541.00681-2021. eCollection 2022 Apr.
4
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.以患者为中心的间质性肺疾病结局研究:美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2021 Jul 15;204(2):e3-e23. doi: 10.1164/rccm.202105-1193ST.
5
Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study.评估基于锚点的患者报告结局最小重要差异估计值的可信度:仪器开发和可靠性研究。
BMJ. 2020 Jun 4;369:m1714. doi: 10.1136/bmj.m1714.
6
The anchor-based minimal important change, based on receiver operating characteristic analysis or predictive modeling, may need to be adjusted for the proportion of improved patients.基于接收器操作特征分析或预测建模的锚定最小重要变化,可能需要根据改善患者的比例进行调整。
J Clin Epidemiol. 2017 Mar;83:90-100. doi: 10.1016/j.jclinepi.2016.12.015. Epub 2017 Jan 14.
7
Minimal important change (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis.基于预测模型方法的最小有意义变化 (MIC) 比基于 ROC 分析的 MIC 更精确。
J Clin Epidemiol. 2015 Dec;68(12):1388-96. doi: 10.1016/j.jclinepi.2015.03.015. Epub 2015 Mar 28.
8
A critical look at transition ratings.对过渡评级的批判性审视。
J Clin Epidemiol. 2002 Sep;55(9):900-8. doi: 10.1016/s0895-4356(02)00435-3.
9
Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach.变化反应性回顾性计算中的方法学问题:克龙巴赫的教训
J Clin Epidemiol. 1997 Aug;50(8):869-79. doi: 10.1016/s0895-4356(97)00097-8.